ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.686,60
1,07%
S&P 500
5.214,08
0,51%
Dow Jones
39.387,76
0,85%
Euro vs US Dollar
1,07763
-0,05%
Bitcoin
62.948,96
-0,16%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. TC BioPharm Holdings PLC (TCBP)

  7. TC BioPharm Holdings PLC (TCBP) News

TCBP TC BioPharm Holdings PLC

1,22
-0,02 (-1,61%)
10 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
TC BioPharm Holdings PLC TCBP NASDAQ Depository Receipt
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
-0,02 -1,61% 1,22 06:00:02
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,25 1,19 1,25 1,22 1,24
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
06.5.202419:01PRNUSTC BioPharm Announces Exercise of Warrants for £3.1 Million..
06.5.202414:30PRNUSTC BioPharm Announces Execution of Second Non-Binding Letter..
04.4.202414:32PRNUSTCBP Announces Execution of Non-Binding Letter of Intent for..
02.4.202414:30PRNUSTCBP Increasing Treatment Capacity with Expanded..
19.3.202413:30PRNUSTCBP Adjourns General Meeting Until a Later Date
18.3.202413:30PRNUSTCBP Announces Exercise of Series D Warrants For Cash
06.3.202412:30EDGAR2Form 8-K - Current report
01.3.202414:30PRNUSBryan Kobel, CEO of TCBP, Appears on Nationally Syndicated..
27.2.202423:15PRNUS/C O R R E C T I O N -- TC BioPharm/
27.2.202414:30PRNUSTCBP Announces Shareholder Update Call on March 5th 2024
22.2.202415:32PRNUSTCBP Announces MHRA Acceptance of Amendment for ACHIEVE UK..
20.2.202412:05EDGAR2Form DEF 14A - Other definitive proxy statements
15.2.202414:30PRNUSTC BioPharm Management to Participate at Upcoming 7th..
14.2.202420:48EDGAR2Form 8-K - Current report
14.2.202414:30PRNUSTCBP Provides Shareholder Update and Highlights Upcoming..
09.2.202421:26EDGAR2Form PRE 14A - Other preliminary proxy statements
29.1.202415:16EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
29.1.202414:30PRNUSTC BioPharm Chief Executive Officer, Bryan Kobel Featured on..
18.1.202414:30PRNUSTC BioPharm to Present at the Sequire Investor Summit
04.1.202414:46EDGAR2Form 8-K - Current report
04.1.202414:30PRNUSTC BioPharm Regains Compliance with Nasdaq Minimum Bid Price..
03.1.202414:30PRNUSTC BioPharm Announces Additional Cost Reduction Steps to..
22.12.202314:30PRNUSTC BioPharm Announces Closing of $3.5 Million Public..
21.12.202323:14EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19.12.202314:00PRNUSTC BioPharm Announces Pricing of $3.5 Million Public..
19.12.202306:15EDGAR2Form EFFECT - Notice of Effectiveness
18.12.202317:15PRNUSTC BioPharm Announces Formation of Commercial Development..
14.12.202323:20EDGAR2Form F-1/A - Registration statement for certain foreign..
13.12.202315:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13.12.202312:30PRNUSTC BioPharm Announces Plan to Implement ADS Ratio Change
27.11.202314:45PRNUSTC BioPharm Announces FDA Clearance of Phase 1B IND for..
14.11.202316:00PRNUSTC BioPharm Announces Successful Completion of Safety Cohort..
08.11.202322:05EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
02.11.202318:30PRNUSTC BioPharm Announces Streamlined Efficiencies and Reduces..
02.11.202318:11EDGAR2Form F-3/A - Registration statement by foreign private..
02.11.202317:57EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25.10.202314:00PRNUSTC BioPharm Selects Excellos as CDMO in Anticipation of..
23.10.202314:00PRNUSTC BioPharm Announces Submission of Investigational New Drug..
29.9.202322:05EDGAR2Form F-3 - Registration statement by foreign private issuers
27.9.202314:00PRNUSTC BioPharm to Present at the LD Micro Main Event XVI
05.9.202314:30PRNUSTC BioPharm Announces Grant Funding in Collaboration with..
01.9.202323:15EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
31.8.202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29.8.202314:30PRNUSTC BioPharm to Present at H.C. Wainwright 25th Annual Global..
28.8.202323:25EDGAR2Form F-1 - Registration statement for certain foreign..
22.8.202322:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31.7.202314:30PRNUSTC BioPharm Maintains Nasdaq Listing
31.7.202314:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24.7.202322:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10.7.202323:29EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

Kürzlich von Ihnen besucht

NASDAQ
TCBP
TC BioPharm
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten